Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

Nigeria flag Nigeria · Delayed Price · Currency is NGN
13.40
+1.20 (9.84%)
At close: Jan 21, 2026
257.33%
Market Cap57.26B
Revenue (ttm)6.40B
Net Income (ttm)-856.05M
Shares Out4.27B
EPS (ttm)-0.20
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume10,766,430
Average Volume9,122,228
Open13.40
Previous Close12.20
Day's Range13.40 - 13.40
52-Week Range2.42 - 13.40
Beta0.28
RSI85.03
Earnings DateJan 28, 2026

About NGX:NEIMETH

Neimeth International Pharmaceuticals Plc manufactures and markets pharmaceutical and animal health products in Nigeria and Ghana. It provides health care, ethical, and veterinary related products; and poultry and animal range of anthelmintic products, as well as production enhancing medicaments. The company was formerly known as Pfizer Inc. and changed its name to Neimeth International Pharmaceuticals Plc. In 1997. Neimeth International Pharmaceuticals Plc was incorporated in 1957 and is based in Lagos, Nigeria. [Read more]

Industry Pharmaceutical Preparations
Founded 1957
Employees 175
Stock Exchange Nigerian Stock Exchange
Ticker Symbol NEIMETH
Full Company Profile

Financial Performance

In 2024, NGX:NEIMETH's revenue was 4.49 billion, an increase of 102.98% compared to the previous year's 2.21 billion. Losses were -885.33 million, -50.75% less than in 2023.

Financial Statements